[1] Clemens JA,Stephenson DT,Smalstig EB,et al. Global ischemia activat es nucear factor-kappa B in forebrain neu-rons of rats[J]. Stroke,1997,28(5):1073-1081. [2] Takuwva Y. Rho Rho kinase pathway[J]. Nippon Rinsho,2004,62(1):43-48. [3] Kataoka C,Egashira K,InoueS,et al. Important role of Rho kinase in the pathogenesis of cardiovascu lar inflammation and remocdeling induced by long temm blockade of nitric oxide synthesis in rats[J]. Hypertension,2002,39(2):245-250. [4] Kawaguchi A,Ohmori M,Fu jimura A. Partial protective effedt of Y 27632,a Rho kinase inhibitor,against hepatic ischemia reperfusion injury in rats[J].Eur J Phamacol, [5] Rikitake Y,Kim HH,Huang Z,et al Inhibition of Rho.kinase (ROCK) leads to increased cerebral blood flow and stroke protection[J]. Stroke,2005,36 (10):2251-2257. [6] Yamashita K,Kotani Y,Nakajima Y,et al. Fasudil,a Rho kinase (ROCK) inhibitor,protects against ischemic neuronal damage in vito and in vivo by acting directly on neurons[J]. Brain Res,2007,1154:215-224. [7] Yagita Y,Kitagawa K,Sasaki T,et al. Rho kinase adi-vation in endothelial cells contributes to expansion of in-farction after focal cerebral ischemia[J]. J Neurosci Res,2007,85(11):2460-2469. [8] Satoh S,UtsunomiyaT,Tsurui K,et al. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage[J]. Life Sci,2001,69(12):1441-1453. [9] Longa EZ,Weinstein PR,Carlson S,et al. Reversible middle cerebral artery occusion without craniectomy in rats[J]. Stroke,1989,20(1):84-91. [10] Bederson JB,Pitts IH,Tsuji M,et al. Rat middle cerebral artery ocdlusion:evaluation of the model and development of a neurologic examination[J]. Stroke,1986,17(3):472-476. [11] Zhou YH,Yu JP,liuYF,et al. Efects of Ginkgo biloba extract on inflammatory mediators (SOD,MDA,TNF-al-pha,NF-kappaBp65,IL6) in TNBS induced colitis in rat[J]. Mediators Inflamm,2006,2006(5):92642. [12] Segain JP,Raingeard de la Bletiere D,Sauzeau V,et al.Rho kinase blockade prevents inflammation via nudear factor kappa B inhibition:evidence in Crohn' s disease and experimental colitis[J]. Gastroenterology,2003,124(5):1180-1187. [13] Nakakuki T,Ito M,Iwasaki H,et al. Rho/Rhork inase pathway contributes to C-reactive protein induced plas-minogen activator inhibitor 1 expression in endothelial cells[J]. Arteriosder Thromb Vasc Biol,2005,25(10):2088-2093. [14] Bolick DT,OrrAW,Whetzel A,et al. 12/15 lipoxygenr ase regulates int ercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor kappaB[J].rteni oscler Thromb Vasc Biol,2005,25(11):2301-2307. |